Embecta Corp (EMBC)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $366.02M
Last updated: Nov 17, 2026 at 11:05 AM ET
Embecta Corp (EMBC) Financials: Revenue, Profit and Cash Flow
Embecta reported revenue of $1.08B for the fiscal year ended Sep 30, 2025, down 3.8% from the year before. That year, net income was $95.40M with a net margin of 8.8%, operating cash flow was $191.70M and free cash flow was $182.40M. The quarter ended Jun 30, 2026 had revenue of $271.70M and net income of $21.10M.
Revenue and Margins
The operating margin was 22.4% in the fiscal year ended Sep 2025. Over the 6 years to Sep 2025, revenue fell from $1.11B, a compound annual decline of 0.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Sep 2025 | $1.08B | -3.8% | 62.6% | 22.4% | 8.8% |
| Sep 2024 | $1.12B | +0.2% | 65.5% | 14.9% | 7.0% |
| Sep 2023 | $1.12B | -0.8% | 66.9% | 19.8% | 6.3% |
| Sep 2022 | $1.13B | -3.1% | 68.6% | 27.4% | 19.8% |
| Sep 2021 | $1.17B | +7.4% | 68.7% | 42.2% | 35.6% |
| Sep 2020 | $1.09B | -2.1% | 70.3% | 44.8% | 39.4% |
| Sep 2019 | $1.11B | N/A | 70.9% | 45.3% | 39.0% |
Income Statement
In the fiscal year ended Sep 2025, net income rose 21.8% from the year before. In the quarter ended Jun 2026, net income fell 53.6% from the same quarter a year earlier.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.08B | $1.12B | $1.12B | $1.13B | $1.17B | $1.09B | $1.11B |
| Cost of revenue | $403.60M | $387.90M | $370.90M | $354.60M | $364.90M | $322.90M | $323.00M |
| Gross profit | $676.80M | $735.20M | $749.90M | $774.90M | $800.40M | $762.60M | $786.00M |
| Research and development | $37.30M | $78.80M | $85.20M | $66.90M | $63.30M | $61.40M | $62.00M |
| Operating income | $242.10M | $166.80M | $221.50M | $309.60M | $492.00M | $486.50M | $502.00M |
| Net income | $95.40M | $78.30M | $70.40M | $223.60M | $414.80M | $427.60M | $432.00M |
| EBITDA | $303.80M | $205.90M | $251.70M | $337.70M | $533.20M | $524.80M | $536.00M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $271.70M | $221.80M | $261.20M | $264.00M | $295.50M | $259.00M | $261.90M | $286.10M | $272.50M | $287.20M | $277.30M | $281.90M |
| Gross profit | $153.30M | $127.80M | $161.70M | $158.50M | $197.10M | $164.10M | $157.10M | $173.80M | $190.10M | $185.40M | $185.90M | $181.80M |
| Operating income | $48.70M | $35.00M | $83.30M | $56.50M | $94.00M | $62.90M | $28.70M | $26.20M | $55.90M | $39.20M | $45.50M | $25.80M |
| Net income | $21.10M | -$4.10M | $44.10M | $26.40M | $45.50M | $23.50M | $0 | $14.60M | $14.70M | $28.90M | $20.10M | $6.00M |
Balance Sheet
As of Sep 2025, total debt of $1.40B exceeded cash and equivalents by $1.17B. Shareholder equity was negative, at -$650.60M, as total liabilities of $1.74B exceeded total assets of $1.09B.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 |
|---|---|---|---|---|---|---|---|
| Total assets | $1.09B | $1.29B | $1.21B | $1.09B | $788.00M | $738.00M | $745.00M |
| Current assets | $631.40M | $761.00M | $749.10M | $664.70M | $291.80M | $235.00M | $248.00M |
| Cash and equivalents | $225.50M | $267.50M | $326.30M | $330.90M | $0 | N/A | N/A |
| Total liabilities | $1.74B | $2.02B | $2.04B | $1.98B | $193.70M | $166.00M | $126.00M |
| Short-term debt | $9.50M | $9.50M | $9.50M | $9.50M | $0 | $1.00M | N/A |
| Long-term debt | $1.39B | $1.57B | $1.59B | $1.60B | $0 | N/A | N/A |
| Shareholder equity | -$650.60M | -$738.30M | -$821.70M | -$891.40M | $594.30M | $572.00M | $577.00M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.27B | $1.03B | $1.06B | $1.09B | $1.16B | $1.12B | $1.15B | $1.29B | $1.27B | $1.20B | $1.22B | $1.21B |
| Total liabilities | $1.88B | $1.66B | $1.68B | $1.74B | $1.83B | $1.86B | $1.92B | $2.02B | $2.03B | $1.97B | $2.01B | $2.04B |
| Cash and equivalents | $214.70M | $184.90M | $201.30M | $225.50M | $230.60M | $209.30M | $210.00M | $267.50M | $275.10M | $299.80M | $298.70M | $326.30M |
| Shareholder equity | -$612.70M | -$626.10M | -$613.10M | -$651.20M | -$669.60M | -$736.20M | -$768.80M | -$738.30M | -$763.70M | -$769.60M | -$793.50M | -$821.70M |
Cash Flow
In the fiscal year ended Sep 2025, free cash flow was 95.1% of operating cash flow. Dividends came to 19.2% of it.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $191.70M | $35.70M | $67.70M | $412.20M | $456.30M | $498.50M | $505.00M |
| Capital expenditures | $9.30M | $15.80M | $26.50M | $23.60M | $36.80M | $41.90M | $69.00M |
| Free cash flow | $182.40M | $19.90M | $41.20M | $388.60M | $419.50M | $456.60M | $436.00M |
| Dividends paid | $35.00M | $34.50M | $34.40M | $8.60M | $0 | $0 | $8.60M |
| Investing cash flow | -$9.30M | -$15.80M | -$26.50M | -$24.00M | -$39.20M | -$41.90M | -$69.00M |
| Financing cash flow | -$226.70M | -$73.40M | -$48.70M | -$48.00M | -$417.10M | -$456.60M | -$436.00M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $41.80M | $31.10M | $17.20M | $84.00M | $81.20M | $31.80M | -$5.30M | $26.60M | -$2.10M | $24.30M | -$13.10M | $29.60M |
| Capital expenditures | $1.10M | $500.00K | $600.00K | $7.30M | $400.00K | $100.00K | $1.50M | $0 | $9.70M | $3.40M | $2.70M | $9.20M |
| Free cash flow | $40.70M | $30.60M | $16.60M | $76.70M | $80.80M | $31.70M | -$6.80M | $26.60M | -$11.80M | $20.90M | -$15.80M | $20.40M |
Frequently Asked Questions About EMBC
What is Embecta's annual revenue?
Embecta reported revenue of $1.08B for the fiscal year ended Sep 30, 2025.
How fast is Embecta's revenue growing?
Revenue was down 3.8% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -1.5%.
Is Embecta profitable?
Yes. Embecta reported net income of $95.40M for the fiscal year ended Sep 30, 2025, with a net margin of 8.8%.
How much free cash flow does EMBC generate?
For the fiscal year ended Sep 30, 2025, operating cash flow of $191.70M minus capital expenditures of $9.30M produced free cash flow of $182.40M.
How much debt does Embecta have?
The balance sheet dated Sep 30, 2025 reported long-term debt of $1.39B, short-term debt of $9.50M and cash and equivalents of $225.50M.
EMBC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors